Asia-Pacific Cancer Treatment Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2022
- ID:PD015195
- January 2017
- GIR (Global Info Research)
Single User License: $4,480.00
Multi User License:
Enterprise License: $8,960.00
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Scope of the Report:
This report focuses on the Cancer Treatment Drugs in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Countries, covering
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 19 Chapters to deeply display the Asia-Pacific Cancer Treatment Drugs market.
Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Cancer Treatment Drugs, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application;
Chapter 14, Cancer Treatment Drugs market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Scope of the Report:
This report focuses on the Cancer Treatment Drugs in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
- Roche
- Novartis
- Celgene
- Amgen
- Johnson & Johnson
- Bristol-Myers Squibb
- Takeda
- Eli Lilly
- Pfizer
- AstraZeneca
- Astellas
- Sanofi
- Bayer
- Merck & Co.
- Biogen Idec
- Kyowa Hakko Kirin
- Otsuka
- Teva
- Eisai
- Merck KGaA
- Ipsen
- AbbVie
- Gilead Sciences
Market Segment by Countries, covering
- China
- Japan
- Korea
- Taiwan
- Southeast Asia
- India
- Australia
Market Segment by Type, covers
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
Market Segment by Applications, can be divided into
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other Cancers
There are 19 Chapters to deeply display the Asia-Pacific Cancer Treatment Drugs market.
Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Cancer Treatment Drugs, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application;
Chapter 14, Cancer Treatment Drugs market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Table of Contents
1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy (Biologic Therapy)
1.2.4 Hormonal Therapy
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Countries
1.4.1 China Status and Prospect (2012-2022)
1.4.2 Korea Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 Taiwan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Australia Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Novartis
2.2.1 Profile
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Novartis News
2.3 Celgene
2.3.1 Profile
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Amgen
2.4.1 Profile
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Amgen News
2.5 Johnson & Johnson
2.5.1 Profile
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Johnson & Johnson News
2.6 Bristol-Myers Squibb
2.6.1 Profile
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Bristol-Myers Squibb News
2.7 Takeda
2.7.1 Profile
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Takeda News
2.8 Eli Lilly
2.8.1 Profile
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Reven ...
1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy (Biologic Therapy)
1.2.4 Hormonal Therapy
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Countries
1.4.1 China Status and Prospect (2012-2022)
1.4.2 Korea Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 Taiwan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Australia Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Novartis
2.2.1 Profile
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Novartis News
2.3 Celgene
2.3.1 Profile
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Amgen
2.4.1 Profile
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Amgen News
2.5 Johnson & Johnson
2.5.1 Profile
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Johnson & Johnson News
2.6 Bristol-Myers Squibb
2.6.1 Profile
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Bristol-Myers Squibb News
2.7 Takeda
2.7.1 Profile
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Takeda News
2.8 Eli Lilly
2.8.1 Profile
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Reven ...
Related Categories :
Chemicals And Materials
www.decisiondatabases.com is a online aggregator of market and research database which includes databases, reports and profiles. We have started this portal with a aim to become one stop shop provider for marketing and research data requirements for various sector and country databases.
Main Categories
